Drug Profile
Glucagon-like peptide 1 7-36 amide intranasal - Asubio Pharma
Alternative Names: CS 872; SUN E7001Latest Information Update: 09 Feb 2010
Price :
$50
*
At a glance
- Originator Asubio Pharma; Daiichi Sankyo Company
- Developer Asubio Pharma
- Class Glucagon-like peptides
- Mechanism of Action Glucagon like peptide 1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 01 Apr 2007 Daiichi Asubio Pharma is now called Asubio Pharma
- 11 Aug 2006 Phase-I clinical trials in Type-2 diabetes mellitus in Japan (Intranasal)
- 11 Aug 2006 Preclinical trials in Type-2 diabetes mellitus in World (Intranasal)